Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

Isotype:
IgG2, Kappa

200.00

+ 200 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb - Research Grade

Product name Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb - Research Grade
Source CAS 745013-59-6
Species Homo sapiens
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Tremelimumab,Ticilimumab, CP-675,CP-675,206,CP-675206 clone 11.2.1,CTLA4, CD152,anti-CTLA4, CD152
Reference PX-TA1177
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2-kappa
Clonality Monoclonal Antibody
Product name Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb - Research Grade
Source CAS 745013-59-6
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Tremelimumab,Ticilimumab, CP-675,CP-675,206,CP-675206 clone 11.2.1,CTLA4, CD152,anti-CTLA4, CD152
Reference PX-TA1177
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2-kappa
Clonality Monoclonal Antibody

General information on Anti-CTLA4/CD152(Homo sapiens) (Tremelimumab) Monoclonal Antibody

Tremelimumab is studied for the treatment of Mesothelioma, Liver Neoplasms, Liver Cancer, Liver Cell Caricinoma, and HepatoCellular Carcinoma.

SDS-PAGE for Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb

SDS-PAGE for Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb

Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb binds to CD152 Recombinant Protein in Indirect ELISA Assay

Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb binds to CD152 Recombinant Protein in Indirect ELISA Assay

Immobilized CD152 Recombinant Protein (cat. No.PX-P4108) at 0.5µg/mL (100µL/well) can bind to Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb (cat. No.PX-TA1177) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products